Drugs affecting lipid metabolism:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Berlin u.a.
Springer
1987
|
Schriftenreihe: | Proceedings in life sciences
|
Schlagworte: | |
Beschreibung: | XVI, 451 S. Ill. |
ISBN: | 3540172777 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV000806726 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 880920s1987 a||| |||| 10||| eng d | ||
020 | |a 3540172777 |9 3-540-17277-7 | ||
035 | |a (OCoLC)16950357 | ||
035 | |a (DE-599)BVBBV000806726 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-188 | ||
050 | 0 | |a QU85 | |
050 | 0 | |a RC632.H87 | |
082 | 0 | |a 616.3/997061 |2 19 | |
245 | 1 | 0 | |a Drugs affecting lipid metabolism |c ed. by R. Paoletti ... |
264 | 1 | |a Berlin u.a. |b Springer |c 1987 | |
300 | |a XVI, 451 S. |b Ill. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Proceedings in life sciences | |
650 | 7 | |a Cholestérol - Métabolisme - Congrès |2 ram | |
650 | 4 | |a Cholestérolémie - Métabolisme | |
650 | 4 | |a Hyperlipidémie - Chimiothérapie | |
650 | 7 | |a Hyperlipidémie - Chimiothérapie - Congrès |2 ram | |
650 | 4 | |a Hypolipémiants - Essais | |
650 | 7 | |a Lipoprotéines - Métabolisme - Congrès |2 ram | |
650 | 4 | |a Lipoprotéines plasmatiques - Métabolisme | |
650 | 7 | |a Lipoprotéines plasmatiques - Métabolisme - Congrès |2 ram | |
650 | 4 | |a Antilipemic Agents |v Congresses | |
650 | 4 | |a Antilipemic agents |x Testing | |
650 | 4 | |a Arteriosclerosis |v Congresses | |
650 | 4 | |a Blood cholesterol |x Metabolism | |
650 | 4 | |a Blood lipoproteins |x Metabolism | |
650 | 4 | |a Hyperlipidemia |x Chemotherapy | |
650 | 4 | |a Lipid Metabolism |v Congresses | |
650 | 4 | |a Lipoproteins |x metabolism |v Congresses | |
650 | 4 | |a Metabolism |x drug effects |v Congresses | |
650 | 0 | 7 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lipidsenker |0 (DE-588)4167796-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Atherogenese |0 (DE-588)4195269-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hyperlipidämie |0 (DE-588)4161072-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1986 |z Florenz |2 gnd-content | |
689 | 0 | 0 | |a Lipidsenker |0 (DE-588)4167796-1 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |D s |
689 | 2 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 2 | |8 1\p |5 DE-604 | |
689 | 3 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
689 | 3 | 1 | |a Atherogenese |0 (DE-588)4195269-8 |D s |
689 | 3 | |8 2\p |5 DE-604 | |
689 | 4 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
689 | 4 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 4 | |8 3\p |5 DE-604 | |
689 | 5 | 0 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |D s |
689 | 5 | |8 4\p |5 DE-604 | |
700 | 1 | |a Paoletti, Rodolfo |e Sonstige |4 oth | |
999 | |a oai:aleph.bib-bvb.de:BVB01-000505660 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804115258228342784 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV000806726 |
callnumber-first | Q - Science |
callnumber-label | QU85 |
callnumber-raw | QU85 RC632.H87 |
callnumber-search | QU85 RC632.H87 |
callnumber-sort | QU 285 |
ctrlnum | (OCoLC)16950357 (DE-599)BVBBV000806726 |
dewey-full | 616.3/997061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.3/997061 |
dewey-search | 616.3/997061 |
dewey-sort | 3616.3 6997061 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03375nam a2200853 c 4500</leader><controlfield tag="001">BV000806726</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">880920s1987 a||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540172777</subfield><subfield code="9">3-540-17277-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)16950357</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000806726</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QU85</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC632.H87</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.3/997061</subfield><subfield code="2">19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs affecting lipid metabolism</subfield><subfield code="c">ed. by R. Paoletti ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin u.a.</subfield><subfield code="b">Springer</subfield><subfield code="c">1987</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 451 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Proceedings in life sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cholestérol - Métabolisme - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cholestérolémie - Métabolisme</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hyperlipidémie - Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hyperlipidémie - Chimiothérapie - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypolipémiants - Essais</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipoprotéines - Métabolisme - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoprotéines plasmatiques - Métabolisme</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipoprotéines plasmatiques - Métabolisme - Congrès</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic Agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic agents</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood cholesterol</subfield><subfield code="x">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood lipoproteins</subfield><subfield code="x">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hyperlipidemia</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid Metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoproteins</subfield><subfield code="x">metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolism</subfield><subfield code="x">drug effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Atherogenese</subfield><subfield code="0">(DE-588)4195269-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1986</subfield><subfield code="z">Florenz</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Atherogenese</subfield><subfield code="0">(DE-588)4195269-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paoletti, Rodolfo</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000505660</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1986 Florenz gnd-content |
genre_facet | Konferenzschrift 1986 Florenz |
id | DE-604.BV000806726 |
illustrated | Illustrated |
indexdate | 2024-07-09T15:19:45Z |
institution | BVB |
isbn | 3540172777 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000505660 |
oclc_num | 16950357 |
open_access_boolean | |
owner | DE-12 DE-188 |
owner_facet | DE-12 DE-188 |
physical | XVI, 451 S. Ill. |
publishDate | 1987 |
publishDateSearch | 1987 |
publishDateSort | 1987 |
publisher | Springer |
record_format | marc |
series2 | Proceedings in life sciences |
spelling | Drugs affecting lipid metabolism ed. by R. Paoletti ... Berlin u.a. Springer 1987 XVI, 451 S. Ill. txt rdacontent n rdamedia nc rdacarrier Proceedings in life sciences Cholestérol - Métabolisme - Congrès ram Cholestérolémie - Métabolisme Hyperlipidémie - Chimiothérapie Hyperlipidémie - Chimiothérapie - Congrès ram Hypolipémiants - Essais Lipoprotéines - Métabolisme - Congrès ram Lipoprotéines plasmatiques - Métabolisme Lipoprotéines plasmatiques - Métabolisme - Congrès ram Antilipemic Agents Congresses Antilipemic agents Testing Arteriosclerosis Congresses Blood cholesterol Metabolism Blood lipoproteins Metabolism Hyperlipidemia Chemotherapy Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechsel (DE-588)4035875-6 gnd rswk-swf Lipidsenker (DE-588)4167796-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Atherogenese (DE-588)4195269-8 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Lipidstoffwechselstörung (DE-588)4035876-8 gnd rswk-swf Hyperlipidämie (DE-588)4161072-6 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1986 Florenz gnd-content Lipidsenker (DE-588)4167796-1 s DE-604 Hyperlipidämie (DE-588)4161072-6 s Chemotherapie (DE-588)4127083-6 s Lipidstoffwechsel (DE-588)4035875-6 s Pharmakologie (DE-588)4045687-0 s 1\p DE-604 Atherogenese (DE-588)4195269-8 s 2\p DE-604 Pharmakotherapie (DE-588)4076066-2 s 3\p DE-604 Lipidstoffwechselstörung (DE-588)4035876-8 s 4\p DE-604 Paoletti, Rodolfo Sonstige oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Drugs affecting lipid metabolism Cholestérol - Métabolisme - Congrès ram Cholestérolémie - Métabolisme Hyperlipidémie - Chimiothérapie Hyperlipidémie - Chimiothérapie - Congrès ram Hypolipémiants - Essais Lipoprotéines - Métabolisme - Congrès ram Lipoprotéines plasmatiques - Métabolisme Lipoprotéines plasmatiques - Métabolisme - Congrès ram Antilipemic Agents Congresses Antilipemic agents Testing Arteriosclerosis Congresses Blood cholesterol Metabolism Blood lipoproteins Metabolism Hyperlipidemia Chemotherapy Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechsel (DE-588)4035875-6 gnd Lipidsenker (DE-588)4167796-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd Atherogenese (DE-588)4195269-8 gnd Chemotherapie (DE-588)4127083-6 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Hyperlipidämie (DE-588)4161072-6 gnd Pharmakologie (DE-588)4045687-0 gnd |
subject_GND | (DE-588)4035875-6 (DE-588)4167796-1 (DE-588)4076066-2 (DE-588)4195269-8 (DE-588)4127083-6 (DE-588)4035876-8 (DE-588)4161072-6 (DE-588)4045687-0 (DE-588)1071861417 |
title | Drugs affecting lipid metabolism |
title_auth | Drugs affecting lipid metabolism |
title_exact_search | Drugs affecting lipid metabolism |
title_full | Drugs affecting lipid metabolism ed. by R. Paoletti ... |
title_fullStr | Drugs affecting lipid metabolism ed. by R. Paoletti ... |
title_full_unstemmed | Drugs affecting lipid metabolism ed. by R. Paoletti ... |
title_short | Drugs affecting lipid metabolism |
title_sort | drugs affecting lipid metabolism |
topic | Cholestérol - Métabolisme - Congrès ram Cholestérolémie - Métabolisme Hyperlipidémie - Chimiothérapie Hyperlipidémie - Chimiothérapie - Congrès ram Hypolipémiants - Essais Lipoprotéines - Métabolisme - Congrès ram Lipoprotéines plasmatiques - Métabolisme Lipoprotéines plasmatiques - Métabolisme - Congrès ram Antilipemic Agents Congresses Antilipemic agents Testing Arteriosclerosis Congresses Blood cholesterol Metabolism Blood lipoproteins Metabolism Hyperlipidemia Chemotherapy Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechsel (DE-588)4035875-6 gnd Lipidsenker (DE-588)4167796-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd Atherogenese (DE-588)4195269-8 gnd Chemotherapie (DE-588)4127083-6 gnd Lipidstoffwechselstörung (DE-588)4035876-8 gnd Hyperlipidämie (DE-588)4161072-6 gnd Pharmakologie (DE-588)4045687-0 gnd |
topic_facet | Cholestérol - Métabolisme - Congrès Cholestérolémie - Métabolisme Hyperlipidémie - Chimiothérapie Hyperlipidémie - Chimiothérapie - Congrès Hypolipémiants - Essais Lipoprotéines - Métabolisme - Congrès Lipoprotéines plasmatiques - Métabolisme Lipoprotéines plasmatiques - Métabolisme - Congrès Antilipemic Agents Congresses Antilipemic agents Testing Arteriosclerosis Congresses Blood cholesterol Metabolism Blood lipoproteins Metabolism Hyperlipidemia Chemotherapy Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechsel Lipidsenker Pharmakotherapie Atherogenese Chemotherapie Lipidstoffwechselstörung Hyperlipidämie Pharmakologie Konferenzschrift 1986 Florenz |
work_keys_str_mv | AT paolettirodolfo drugsaffectinglipidmetabolism |